SNUH and Syapse will collaboratively work towards building South Korea’s first real-world data-sharing network for leading precision oncology hospitals in the region.
Syapse, a company accelerating precision medicine through insights derived from its global health system network, and Seoul National University Hospital (SNUH), a South Korea-based hospital, today announced that they have extended their partnership with a new multi-year agreement. As part of their partnership, SNUH and Syapse will collaboratively work towards building South Korea’s first real-world data-sharing network for leading precision oncology hospitals in the region.
Syapse Network
The Syapse Network enables health systems and their providers to learn from real-world treatment and outcomes data shared by leading institutions. Providers can view which treatments provided the best outcomes for clinically and molecularly similar patients at the point of care with a large pool of real-world data generated by a national network of leading institutions. Insights are accessible to Syapse health system partners through Syapse Oncology.
SNUH’s Innovation Approach to Cancer Care
Established in 1885 as Korea’s first national hospital, SNUH has built a global reputation for innovative approaches to cancer care. SNUH serves more than 8,000 cancer patients per year across 16 Cancer Specialty Centers, 10 Multidisciplinary Cancer Treatment Centers, and a Cancer Clinical Trials Center. The Syapse and SNUH collaboration, established in January 2018, has focused on scaling the delivery of precision medicine insights through the integration and curation of clinical, molecular testing and outcomes data collected in information systems including electronic health records (EHRs).
Syapse Precision Medicine Council Asia
SNUH and Syapse have also announced today that they will co-host the Syapse Precision Medicine Council Asia with support from MegazoneCloud. The inaugural invitation-only symposium for Syapse partners will be held at SNUH in Seoul on November 22 and 23, 2019 and convene clinical and executive healthcare leaders who are dedicated to advancing precision oncology. The Precision Medicine Council is focused on three primary goals: sharing best practices in growing precision medicine programs, generating actionable insights to advance the industry as a whole, and building upon current data-sharing initiatives.
Why It Matters
“We are very pleased to enter into this expanded multi-year agreement with Syapse focused on accelerating the practice of precision medicine,” said Kyung Hwan Kim, M.D., Ph.D., Chief Information Officer at Seoul National University Hospital. “We are proud of the progress we have made together and look forward to continuing our efforts with Syapse to develop the leading precision medicine platform in South Korea and the Asia Pacific region.”
[irp posts=”50001″ name=”Pfizer, Syapse Partner on Oncology Precision Medicine Using Real-World Evidence (RWE)”]